Hisamitsu Pharmaceutical Co., Inc.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4502.T has a market cap of 6.66T. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4502.T trades at $4,234.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4502.T's P/E ratio is 63.01. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4502.T's ROE of +0.03%. Regarding short-term risk, 4530.T is less volatile compared to 4502.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4507.T has a market cap of 2.05T. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4507.T trades at $2,405.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4507.T's P/E ratio is 12.14. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4507.T's ROE of +0.13%. Regarding short-term risk, 4530.T is less volatile compared to 4507.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4523.T has a market cap of 1.14T. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4523.T trades at $4,050.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4523.T's P/E ratio is 19.61. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4523.T's ROE of +0.07%. Regarding short-term risk, 4530.T is less volatile compared to 4523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4581.T has a market cap of 703.28B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4581.T trades at $8,580.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4581.T's P/E ratio is 83.43. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4581.T's ROE of +0.01%. Regarding short-term risk, 4530.T is more volatile compared to 4581.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4506.T has a market cap of 382.99B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4506.T trades at $964.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4506.T's P/E ratio is -2.18. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4506.T's ROE of -1.18%. Regarding short-term risk, 4530.T is less volatile compared to 4506.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4540.T has a market cap of 330.11B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4540.T trades at $4,347.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4540.T's P/E ratio is 12.16. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4540.T's ROE of +0.10%. Regarding short-term risk, 4530.T is less volatile compared to 4540.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 8129.T has a market cap of 282.29B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 8129.T trades at $4,665.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 8129.T's P/E ratio is 18.98. In terms of profitability, 4530.T's ROE is +0.08%, compared to 8129.T's ROE of +0.07%. Regarding short-term risk, 4530.T is more volatile compared to 8129.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4887.T has a market cap of 229.75B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4887.T trades at $1,990.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4887.T's P/E ratio is 16.47. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4887.T's ROE of +0.12%. Regarding short-term risk, 4530.T is more volatile compared to 4887.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4516.T has a market cap of 226.59B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4516.T trades at $3,363.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4516.T's P/E ratio is 7.45. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4516.T's ROE of +0.13%. Regarding short-term risk, 4530.T is less volatile compared to 4516.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4551.T has a market cap of 177.94B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4551.T trades at $6,330.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4551.T's P/E ratio is 32.05. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4551.T's ROE of +0.05%. Regarding short-term risk, 4530.T is more volatile compared to 4551.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4547.T has a market cap of 177.86B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4547.T trades at $4,155.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4547.T's P/E ratio is 15.67. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4547.T's ROE of +0.05%. Regarding short-term risk, 4530.T is less volatile compared to 4547.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4521.T has a market cap of 151.87B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4521.T trades at $4,010.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4521.T's P/E ratio is 7.40. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4521.T's ROE of +0.14%. Regarding short-term risk, 4530.T is more volatile compared to 4521.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4553.T has a market cap of 130.65B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4553.T trades at $2,654.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4553.T's P/E ratio is 6.78. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4553.T's ROE of +0.12%. Regarding short-term risk, 4530.T is less volatile compared to 4553.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4534.T has a market cap of 106.38B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4534.T trades at $3,095.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4534.T's P/E ratio is 19.17. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4534.T's ROE of +0.04%. Regarding short-term risk, 4530.T is less volatile compared to 4534.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4559.T has a market cap of 95.92B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4559.T trades at $2,176.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4559.T's P/E ratio is 12.73. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4559.T's ROE of +0.09%. Regarding short-term risk, 4530.T is less volatile compared to 4559.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4569.T has a market cap of 85.48B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4569.T trades at $1,488.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4569.T's P/E ratio is 18.24. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4569.T's ROE of +0.03%. Regarding short-term risk, 4530.T is less volatile compared to 4569.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4886.T has a market cap of 61.79B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4886.T trades at $2,326.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4886.T's P/E ratio is 12.72. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4886.T's ROE of +0.08%. Regarding short-term risk, 4530.T is less volatile compared to 4886.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4554.T has a market cap of 32.00B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4554.T trades at $1,310.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4554.T's P/E ratio is 7.24. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4554.T's ROE of +0.10%. Regarding short-term risk, 4530.T is less volatile compared to 4554.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4577.T has a market cap of 31.73B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4577.T trades at $2,095.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4577.T's P/E ratio is 14.81. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4577.T's ROE of +0.04%. Regarding short-term risk, 4530.T is less volatile compared to 4577.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 9273.T has a market cap of 28.77B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 9273.T trades at $683.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 9273.T's P/E ratio is 8.20. In terms of profitability, 4530.T's ROE is +0.08%, compared to 9273.T's ROE of +0.14%. Regarding short-term risk, 4530.T is less volatile compared to 9273.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4595.T has a market cap of 28.65B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4595.T trades at $1,504.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4595.T's P/E ratio is 7.59. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4595.T's ROE of +0.23%. Regarding short-term risk, 4530.T is less volatile compared to 4595.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 2929.T has a market cap of 27.55B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 2929.T trades at $948.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 2929.T's P/E ratio is 10.08. In terms of profitability, 4530.T's ROE is +0.08%, compared to 2929.T's ROE of +0.24%. Regarding short-term risk, 4530.T is less volatile compared to 2929.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4538.T has a market cap of 19.66B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4538.T trades at $2,302.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4538.T's P/E ratio is 8.94. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4538.T's ROE of +0.07%. Regarding short-term risk, 4530.T is less volatile compared to 4538.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4574.T has a market cap of 13.90B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4574.T trades at $277.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4574.T's P/E ratio is -5.58. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4574.T's ROE of -0.47%. Regarding short-term risk, 4530.T is less volatile compared to 4574.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4512.T has a market cap of 10.69B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4512.T trades at $308.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4512.T's P/E ratio is 56.41. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4512.T's ROE of +0.00%. Regarding short-term risk, 4530.T is less volatile compared to 4512.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4524.T has a market cap of 8.53B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4524.T trades at $2,084.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4524.T's P/E ratio is 20.96. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4524.T's ROE of +0.03%. Regarding short-term risk, 4530.T is more volatile compared to 4524.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 7079.T has a market cap of 8.27B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 7079.T trades at $3,440.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 7079.T's P/E ratio is 8.73. In terms of profitability, 4530.T's ROE is +0.08%, compared to 7079.T's ROE of +0.25%. Regarding short-term risk, 4530.T is more volatile compared to 7079.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4892.T has a market cap of 8.07B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4892.T trades at $972.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4892.T's P/E ratio is -8.98. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4892.T's ROE of -0.31%. Regarding short-term risk, 4530.T is more volatile compared to 4892.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4582.T has a market cap of 7.55B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4582.T trades at $155.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4582.T's P/E ratio is -1.82. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4582.T's ROE of -0.67%. Regarding short-term risk, 4530.T is less volatile compared to 4582.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4597.T has a market cap of 7.24B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4597.T trades at $33.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4597.T's P/E ratio is -3.38. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4597.T's ROE of -1.08%. Regarding short-term risk, 4530.T is less volatile compared to 4597.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4539.T has a market cap of 5.52B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4539.T trades at $1,530.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4539.T's P/E ratio is -21.51. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4539.T's ROE of -0.01%. Regarding short-term risk, 4530.T is less volatile compared to 4539.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4883.T has a market cap of 5.47B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4883.T trades at $73.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4883.T's P/E ratio is -2.56. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4883.T's ROE of -0.64%. Regarding short-term risk, 4530.T is less volatile compared to 4883.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4586.T has a market cap of 3.19B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4586.T trades at $62.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4586.T's P/E ratio is -4.64. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4586.T's ROE of -0.35%. Regarding short-term risk, 4530.T is less volatile compared to 4586.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.

4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4530.T stands at 318.48B. In comparison, 4541.T has a market cap of 2.47B. Regarding current trading prices, 4530.T is priced at $4,365.00, while 4541.T trades at $35.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4530.T currently has a P/E ratio of 14.77, whereas 4541.T's P/E ratio is -0.00. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4541.T's ROE of +0.13%. Regarding short-term risk, 4530.T is less volatile compared to 4541.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.